Young and Wagih S El Masri continued editing the text of the Declaration. On April 26, the General Assembly unanimously adopted the revised "Beijing Declaration" and reached a consensus to publish the Declaration through various channels and translate it into 11 languages, so that professionals and the general public could more easily gain understanding of these new disciplines, new research areas, and new ways of thinking. The contents of "Beijing Declaration" include neurorestoratology's concept and definition, area of research, intervention methods, objective and key points of the discipline, neurorestoratology direction and guidelines. After the discussion, decision was made to host the 3rd IANRAC in China in April, 2010; the 4th IANRAC would be hosted in Jordan in April, 2011.
Cell and tissue transplantations
Almudena Ramón-Cueto (Spain) grafted olfactory bulb ensheathing glia (OB-OEG) immediately after spinal cord injury (SCI), sub-acute and chronic in rodents. Their results showed that adult OB-OEG exerted a healing effect on the chronic spinal lesion, which provided new perspectives for its application in patients with chronic spinal cord injury. Geoffrey Raisman and Ying LI (UK) made an excellent report on restoration of fore-paw function in a rat model of repair of brachial plexus injury. They proposed that the first successful clinical application of human olfactory ensheathing cells (OECs) in brachial plexus injury would provide a more brilliant future for the treatment of brain and spinal cord injuries. Da-Qing LI (UK) reported their studies of OECs from adult human nasal mucosa. Elena Rem Chernykh (Russia) treated 36 patients in late period of SCI by meningomyeloradiculolis surgery alone or supplemented by autologous bone marrow cell transplantation. They compared the neural functions of the 2 group patients after the treatment, and found that the neural function in patients of the second group was obviously improved. Lin CHEN (China) analyzed the therapeutic effects of OEC transplantation in 1255 patients with central nervous system diseases, and then drew a conclusion: OEC transplantation into brain and spinal cord was feasible and safe. The therapeutic strategy was valuable for treatments of central nervous system diseases such as chronic SCI, amyotrophic lateral sclerosis, cerebral palsy, and sequelae of stroke. It could improve the patients' neurological functions and/or lessen the worsening tendency. Albert Bohbot presented the follow-up records and progress of individuals who had 
